465 related articles for article (PubMed ID: 18849144)
1. Circulating adipokines and the protective effects of hyperinsulinemia in inflammatory bowel disease.
Valentini L; Wirth EK; Schweizer U; Hengstermann S; Schaper L; Koernicke T; Dietz E; Norman K; Buning C; Winklhofer-Roob BM; Lochs H; Ockenga J
Nutrition; 2009 Feb; 25(2):172-81. PubMed ID: 18849144
[TBL] [Abstract][Full Text] [Related]
2. The effect of infliximab on circulating levels of leptin, adiponectin and resistin in patients with inflammatory bowel disease.
Karmiris K; Koutroubakis IE; Xidakis C; Polychronaki M; Kouroumalis EA
Eur J Gastroenterol Hepatol; 2007 Sep; 19(9):789-94. PubMed ID: 17700265
[TBL] [Abstract][Full Text] [Related]
3. Resistin is an inflammatory marker of inflammatory bowel disease in humans.
Konrad A; Lehrke M; Schachinger V; Seibold F; Stark R; Ochsenkühn T; Parhofer KG; Göke B; Broedl UC
Eur J Gastroenterol Hepatol; 2007 Dec; 19(12):1070-4. PubMed ID: 17998831
[TBL] [Abstract][Full Text] [Related]
4. Malnutrition and impaired muscle strength in patients with Crohn's disease and ulcerative colitis in remission.
Valentini L; Schaper L; Buning C; Hengstermann S; Koernicke T; Tillinger W; Guglielmi FW; Norman K; Buhner S; Ockenga J; Pirlich M; Lochs H
Nutrition; 2008; 24(7-8):694-702. PubMed ID: 18499398
[TBL] [Abstract][Full Text] [Related]
5. Reduced serum insulin-like growth factor-1 (IGF-1) and IGF-binding protein-3 levels in adults with inflammatory bowel disease.
Katsanos KH; Tsatsoulis A; Christodoulou D; Challa A; Katsaraki A; Tsianos EV
Growth Horm IGF Res; 2001 Dec; 11(6):364-7. PubMed ID: 11914023
[TBL] [Abstract][Full Text] [Related]
6. Leptin, adiponectin, resistin, and ghrelin--implications for inflammatory bowel disease.
Karmiris K; Koutroubakis IE; Kouroumalis EA
Mol Nutr Food Res; 2008 Aug; 52(8):855-66. PubMed ID: 18383234
[TBL] [Abstract][Full Text] [Related]
7. Serum adipokines in inflammatory bowel disease.
Waluga M; Hartleb M; Boryczka G; Kukla M; Zwirska-Korczala K
World J Gastroenterol; 2014 Jun; 20(22):6912-7. PubMed ID: 24944482
[TBL] [Abstract][Full Text] [Related]
8. Adipokines influencing metabolic and cardiovascular disease are differentially regulated in maintenance hemodialysis.
Ziegelmeier M; Bachmann A; Seeger J; Lossner U; Kratzsch J; Blüher M; Stumvoll M; Fasshauer M
Metabolism; 2008 Oct; 57(10):1414-21. PubMed ID: 18803947
[TBL] [Abstract][Full Text] [Related]
9. Impact of antiretroviral therapy on visfatin and retinol-binding protein 4 in HIV-infected subjects.
Schindler K; Haider D; Wolzt M; Rieger A; Gmeinhart B; Luger A; Nowotny P; Ludvik B
Eur J Clin Invest; 2006 Sep; 36(9):640-6. PubMed ID: 16919047
[TBL] [Abstract][Full Text] [Related]
10. Circulating levels of leptin, adiponectin, resistin, and ghrelin in inflammatory bowel disease.
Karmiris K; Koutroubakis IE; Xidakis C; Polychronaki M; Voudouri T; Kouroumalis EA
Inflamm Bowel Dis; 2006 Feb; 12(2):100-5. PubMed ID: 16432373
[TBL] [Abstract][Full Text] [Related]
11. Plasma levels of PBEF/Nampt/visfatin are decreased in patients with liver cirrhosis.
de Boer JF; Bahr MJ; Böker KH; Manns MP; Tietge UJ
Am J Physiol Gastrointest Liver Physiol; 2009 Feb; 296(2):G196-201. PubMed ID: 19074645
[TBL] [Abstract][Full Text] [Related]
12. Inflammatory mediators and acute phase proteins in patients with Crohn's disease and ulcerative colitis.
Niederau C; Backmerhoff F; Schumacher B; Niederau C
Hepatogastroenterology; 1997; 44(13):90-107. PubMed ID: 9058126
[TBL] [Abstract][Full Text] [Related]
13. The insulin-like growth factor (IGF)-system in active ulcerative colitis and Crohn's disease: relations to disease activity and corticosteroid treatment.
Eivindson M; Grønbaek H; Flyvbjerg A; Frystyk J; Zimmermann-Nielsen E; Dahlerup JF
Growth Horm IGF Res; 2007 Feb; 17(1):33-40. PubMed ID: 17126585
[TBL] [Abstract][Full Text] [Related]
14. Serum leptin, resistin, and lipid levels in patients with end stage renal failure with regard to dialysis modality.
Taskapan MC; Taskapan H; Sahin I; Keskin L; Atmaca H; Ozyalin F
Ren Fail; 2007; 29(2):147-54. PubMed ID: 17365928
[TBL] [Abstract][Full Text] [Related]
15. Relationships between serum adiponectin, leptin, resistin, visfatin levels and bone mineral density, and bone biochemical markers in Chinese men.
Peng XD; Xie H; Zhao Q; Wu XP; Sun ZQ; Liao EY
Clin Chim Acta; 2008 Jan; 387(1-2):31-5. PubMed ID: 17884030
[TBL] [Abstract][Full Text] [Related]
16. Circulating leptin and adiponectin and their relation to glucose metabolism in children with Crohn's disease and ulcerative colitis.
Chouliaras G; Panayotou I; Margoni D; Mantzou E; Pervanidou P; Manios Y; Chrousos GP; Roma E
Pediatr Res; 2013 Oct; 74(4):420-6. PubMed ID: 23823177
[TBL] [Abstract][Full Text] [Related]
17. Elevated circulating platelet-derived microparticles in patients with active inflammatory bowel disease.
Andoh A; Tsujikawa T; Hata K; Araki Y; Kitoh K; Sasaki M; Yoshida T; Fujiyama Y
Am J Gastroenterol; 2005 Sep; 100(9):2042-8. PubMed ID: 16128950
[TBL] [Abstract][Full Text] [Related]
18. Elevated thrombopoietin serum levels in patients with inflammatory bowel disease.
Kapsoritakis AN; Potamianos SP; Sfiridaki AI; Koukourakis MI; Koutroubakis IE; Roussomoustakaki MI; Manousos ON; Kouroumalis EA
Am J Gastroenterol; 2000 Dec; 95(12):3478-81. PubMed ID: 11151880
[TBL] [Abstract][Full Text] [Related]
19. High plasma C-reactive protein (CRP) is related to low paraoxonase-I (PON-I) activity independently of high leptin and low adiponectin in type 2 diabetes mellitus.
Dullaart RP; de Vries R; Sluiter WJ; Voorbij HA
Clin Endocrinol (Oxf); 2009 Feb; 70(2):221-6. PubMed ID: 18505467
[TBL] [Abstract][Full Text] [Related]
20. Association of humoral markers of inflammation and dehydroepiandrosterone sulfate or cortisol serum levels in patients with chronic inflammatory bowel disease.
Straub RH; Vogl D; Gross V; Lang B; Schölmerich J; Andus T
Am J Gastroenterol; 1998 Nov; 93(11):2197-202. PubMed ID: 9820396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]